Trexquant Investment’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-87,256
| Closed | -$1.37M | – | 1936 |
|
|
2024
Q1 | $1.37M | Sell |
87,256
-48,738
| -36% | -$750K | 0.03% | 793 |
|
|
2023
Q4 | $2.19M | Buy |
+135,994
| New | +$1.73M | 0.05% | 522 |
|
|
2023
Q3 | – | Sell |
-36,402
| Closed | -$513K | – | 1910 |
|
|
2023
Q2 | $513K | Sell |
36,402
-24,068
| -40% | -$344K | 0.01% | 990 |
|
|
2023
Q1 | $934K | Buy |
60,470
+37,655
| +165% | +$629K | 0.03% | 759 |
|
|
2022
Q4 | $374K | Sell |
22,815
-8,323
| -27% | -$135K | 0.01% | 1020 |
|
|
2022
Q3 | $576K | Buy |
+31,138
| New | +$489K | 0.02% | 752 |
|
|
2022
Q1 | – | Sell |
-14,299
| Closed | -$140K | – | 1821 |
|
|
2021
Q4 | $140K | Buy |
+14,299
| New | +$269K | 0.01% | 1203 |
|
|
2020
Q2 | – | Sell |
-29,634
| Closed | -$1.22M | – | 1559 |
|
|
2020
Q1 | $1.22M | Buy |
29,634
+21,503
| +264% | +$1.19M | 0.09% | 350 |
|
|
2019
Q4 | $506K | Buy |
8,131
+538
| +7% | +$25.6K | 0.03% | 559 |
|
|
2019
Q3 | $258K | Buy |
+7,593
| New | +$225K | 0.02% | 667 |
|
|
2019
Q2 | – | Sell |
-17,708
| Closed | -$411K | – | 1197 |
|
|
2019
Q1 | $411K | Buy |
+17,708
| New | +$463K | 0.03% | 641 |
|
|
2018
Q3 | – | Sell |
-5,153
| Closed | -$203K | – | 1249 |
|
|
2018
Q2 | $203K | Buy |
+5,153
| New | +$152K | 0.01% | 784 |
|
Other funds holding DCPH
Trexquant Investment's DCPH Position: Q2 2024 in Review
Trexquant Investment sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 87,256 shares — an estimated $1.37M sold.
Trexquant Investment first reported a position in DCPH in Q2 2018 and held it in 12 quarters. The position peaked at $2.19M in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Trexquant Investment reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Trexquant Investment sold 87,256 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.37M.
- Trexquant Investment first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 12 quarters.
- Trexquant Investment's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.19M in Q4 2023.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Trexquant Investment's 13F filing for Q2 2024, filed 13 Aug 2024.